Research Article
Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study
Figure 1
Serum Endocan levels were statistically significantly lower in overweight and obese patients compared to healthy controls (, Mann-Whitney test).